Castle Biosciences Honored with Multiple Top Workplaces Awards Recognizing the Company’s Strong Culture
Castle Biosciences (Nasdaq: CSTL) has received multiple prestigious workplace awards in 2025, highlighting its strong corporate culture and employee satisfaction. The company earned its third consecutive national Healthcare Industry Top Workplaces award, ranking third in its size bracket, and a fourth consecutive Arizona Top Workplaces award.
Additionally, Castle secured five Top Workplaces Culture Excellence awards for Innovation, Work-Life Flexibility, Compensation & Benefits, Leadership, and Purpose & Values. These recognitions are based on anonymous employee feedback collected through third-party surveys by Energage, demonstrating Castle's successful implementation of its people-first culture and commitment to employee satisfaction.
Castle Biosciences (Nasdaq: CSTL) ha ricevuto numerosi prestigiosi premi come luogo di lavoro nel 2025, sottolineando la sua solida cultura aziendale e la soddisfazione dei dipendenti. L'azienda ha conquistato il suo terzo premio nazionale consecutivo Healthcare Industry Top Workplaces, posizionandosi terza nella sua categoria di dimensioni, oltre a un quarto premio consecutivo Arizona Top Workplaces.
Inoltre, Castle ha ottenuto cinque riconoscimenti Top Workplaces Culture Excellence per Innovazione, Flessibilità tra vita privata e lavoro, Retribuzione e Benefici, Leadership e Scopo & Valori. Questi premi si basano su feedback anonimi dei dipendenti raccolti tramite sondaggi di terze parti condotti da Energage, dimostrando l’efficace attuazione della cultura incentrata sulle persone e l’impegno verso la soddisfazione dei lavoratori da parte di Castle.
Castle Biosciences (Nasdaq: CSTL) ha recibido múltiples premios prestigiosos como lugar de trabajo en 2025, destacando su fuerte cultura corporativa y la satisfacción de sus empleados. La compañía obtuvo su tercer premio nacional consecutivo Healthcare Industry Top Workplaces, ubicándose en tercer lugar dentro de su categoría de tamaño, así como un cuarto premio consecutivo Arizona Top Workplaces.
Además, Castle consiguió cinco premios Top Workplaces Culture Excellence por Innovación, Flexibilidad entre vida laboral y personal, Compensación y Beneficios, Liderazgo y Propósito & Valores. Estos reconocimientos se basan en opiniones anónimas de empleados recogidas mediante encuestas de terceros realizadas por Energage, demostrando la exitosa implementación de una cultura centrada en las personas y el compromiso con la satisfacción de los empleados por parte de Castle.
Castle Biosciences (나스닥: CSTL)는 2025년에 여러 권위 있는 직장 상을 수상하며 강력한 기업 문화와 직원 만족도를 강조했습니다. 회사는 3년 연속 전국 헬스케어 산업 최우수 직장상을 수상했으며, 규모별 부문에서 3위를 차지했고, 4년 연속 애리조나 최우수 직장상도 받았습니다.
또한 Castle은 혁신, 일과 삶의 유연성, 보상 및 복리후생, 리더십, 목적 및 가치 부문에서 5개의 최우수 직장 문화 우수상(Top Workplaces Culture Excellence awards)을 획득했습니다. 이 상들은 Energage가 실시한 제3자 설문조사를 통해 익명으로 수집된 직원들의 피드백을 바탕으로 하며, Castle이 사람 중심 문화를 성공적으로 구현하고 직원 만족에 전념하고 있음을 보여줍니다.
Castle Biosciences (Nasdaq : CSTL) a reçu plusieurs prix prestigieux en tant que lieu de travail en 2025, mettant en avant sa forte culture d’entreprise et la satisfaction de ses employés. L’entreprise a obtenu son troisième prix national consécutif Healthcare Industry Top Workplaces, se classant troisième dans sa catégorie de taille, ainsi qu’un quatrième prix consécutif Arizona Top Workplaces.
De plus, Castle a remporté cinq prix d’excellence de la culture Top Workplaces pour l’Innovation, la Flexibilité entre vie professionnelle et vie privée, la Rémunération & les Avantages, le Leadership et la Finalité & les Valeurs. Ces distinctions reposent sur des retours anonymes des employés recueillis via des enquêtes tierces menées par Energage, démontrant la réussite de Castle dans la mise en œuvre de sa culture centrée sur les personnes et son engagement envers la satisfaction des employés.
Castle Biosciences (Nasdaq: CSTL) hat im Jahr 2025 mehrere renommierte Auszeichnungen als Arbeitsplatz erhalten, die seine starke Unternehmenskultur und Mitarbeiterzufriedenheit hervorheben. Das Unternehmen erhielt seinen dritten nationalen Healthcare Industry Top Workplaces Award in Folge und belegte den dritten Platz in seiner Größenklasse sowie den vierten aufeinanderfolgenden Arizona Top Workplaces Award.
Darüber hinaus sicherte sich Castle fünf Top Workplaces Culture Excellence Auszeichnungen für Innovation, Work-Life-Flexibilität, Vergütung & Benefits, Führung und Zweck & Werte. Diese Anerkennungen basieren auf anonymem Mitarbeiterfeedback, das durch Drittanbieter-Umfragen von Energage gesammelt wurde und zeigen, dass Castle seine mitarbeiterorientierte Kultur erfolgreich umsetzt und sich für die Zufriedenheit der Beschäftigten einsetzt.
- None.
- None.
Castle earns recognition as a national Healthcare Industry Top Workplace, an Arizona Top Workplace and receives five Top Workplaces Culture Excellence awards
FRIENDSWOOD, Texas, July 17, 2025 (GLOBE NEWSWIRE) -- Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that it has earned multiple awards through the 2025 Top Workplaces program: a third consecutive national Healthcare Industry Top Workplaces award, with Castle ranking third among other recognized companies in its size bracket; a fourth consecutive regional Arizona Top Workplaces award from AZ Central; and consecutive national Top Workplaces Culture Excellence awards for Innovation, Work-Life Flexibility, Compensation & Benefits, Leadership and Purpose & Values.
“Being recognized as a Top Workplace, year after year, demonstrates the incredible strength of our Castle team and commitment to our shared mission to improve health through innovative tests that guide patient care,” said Derek Maetzold, president and chief executive officer of Castle Biosciences. “These employee-driven honors affirm that our people-first culture isn't just a philosophy, but a catalyst that helps fuel our innovation and impact.”
Top Workplaces awards recognize organizations that have built exceptional workplace cultures, with regional and industry awards celebrating employers of choice within specific areas, and culture excellence awards highlighting organizations that excel in particular aspects of workplace culture. Award designations are garnered solely through anonymous employee feedback gathered through a third-party survey administered by Energage. The confidential survey measures the workplace experience and various culture themes that are indicative of successful organizations, such as employees feeling “fairly valued,” “engaged,” and “respected and supported.”
Castle’s receipt of the Top Workplaces Culture Excellence awards listed below underscores its strong, people-first culture and provides distinction in the following areas:
- Innovation (2022-2025), for embedding innovation into its culture and creating an environment where new ideas come from all employees.
- Work-Life Flexibility (2023-2025), for building a culture that enables employees to meet the demands of their personal lives while maintaining high performance.
- Compensation & Benefits (2022-2025), for providing employees not only with material rewards but also with appreciation for their work.
- Leadership (2022-2025), for organizational leaders who inspire confidence in their employees and in the direction of the company.
- Purpose & Values (2022-2025), for successfully communicating the company mission and integrating those aspirations into the culture.
About Castle Biosciences
Castle Biosciences (Nasdaq: CSTL) is a leading diagnostics company improving health through innovative tests that guide patient care. The Company aims to transform disease management by keeping people first: patients, clinicians, employees and investors.
Castle’s current portfolio consists of tests for skin cancers, Barrett’s esophagus and uveal melanoma. Additionally, the Company has active research and development programs for tests in these and other diseases with high clinical need, including its test in development to help guide systemic therapy selection for patients with moderate-to-severe atopic dermatitis seeking biologic treatment. To learn more, please visit www.CastleBiosciences.com and connect with us on LinkedIn, Facebook, X and Instagram.
DecisionDx-Melanoma, DecisionDx-CMSeq, i31-SLNB, i31-ROR, DecisionDx-SCC, MyPath Melanoma, TissueCypher, DecisionDx-UM, DecisionDx-PRAME and DecisionDx-UMSeq are trademarks of Castle Biosciences, Inc.
Investor Contact:
Camilla Zuckero
czuckero@castlebiosciences.com
Media Contact:
Allison Marshall
amarshall@castlebiosciences.com
